SCHEMBL3868438

SCHEMBL3868438

O=C(O)C(Cc1ccccc1)c1ccc2[nH]c(-c3ccc(Cl)s3)nc2c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ F10 P00742 12/20 0.40
▸ P4HTM Q9NXG6 1/20 0.39
▸ KDM4E B2RXH2 2/20 0.38
▸ ALDH1A1 P00352 2/20 0.38
▸ SMN1; SMN2 Q16637 2/20 0.38
▸ KMT2A Q03164 2/20 0.38
▸ MEN1 O00255 1/20 0.38
▸ LMNA P02545 1/20 0.38
▸ GLA P06280 1/20 0.38
▸ GAA P10253 1/20 0.38
▸ PPARG P37231 1/20 0.38
▸ NCOA2 Q15596 1/20 0.38
▸ NCOA1 Q15788 1/20 0.38
▸ NPSR1 Q6W5P4 1/20 0.38
▸ RXFP1 Q9HBX9 1/20 0.38
▸ HDAC6 Q9UBN7 1/20 0.37
▸ NPC1 O15118 1/20 0.37
▸ TP53 P04637 1/20 0.37
▸ HPGD P15428 1/20 0.37
▸ NFKB1 P19838 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3871590 0.84 F10 (0.38) F10KDM4EALDH1A1SMN1; SMN2KMT2A
SCHEMBL3868441 0.81 F10 (0.40) F10KDM4EALDH1A1SMN1; SMN2KMT2A
SCHEMBL8349167 0.78 F10 (0.38) F10KDM4EALDH1A1SMN1; SMN2GAA
SCHEMBL13759435 0.76 NPSR1 (0.41) F10KDM4EALDH1A1SMN1; SMN2NPSR1
SCHEMBL3861744 0.76 F10 (0.47) F10KDM4EALDH1A1KMT2AMEN1
SCHEMBL3863014 0.74 CSNK2A2 (0.49) F10KDM4EALDH1A1SMN1; SMN2KMT2A
SCHEMBL8346292 0.73 F10 (0.43) F10KDM4EALDH1A1SMN1; SMN2NPC1
SCHEMBL3873919 0.72 PDE2A (0.45) F10
SCHEMBL4687144 0.71 F10 (0.40) F10KDM4EALDH1A1SMN1; SMN2KMT2A
SCHEMBL13759438 0.71 F10 (0.43) F10HDAC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7566789-B2 Benzimidazole derivatives MERCK PATENT GMBH (DE) 2009-07-28 — — US disclosed
US-20050272740-A1 Benzimidazole derivatives MERCK PATENT GMBH (DE) 2005-12-08 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050272740-A1 Benzimidazole derivatives F12, F11, SERPINC1 F10 5/4885P4HTM 1629/4885KDM4E 1595/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback